Pfizer Inc mentioned on Tuesday it should begin a big examine to check its COVID-19 vaccine in youngsters beneath 12 and chosen a dosing regime for the trial.
The examine will enroll as much as 4,500 youngsters at greater than 90 scientific websites in the US, Finland, Poland and Spain, the corporate mentioned.
READ MORE: What we all know in regards to the coronary heart response reported after COVID-19 vaccines
Pfizer’s vaccine has been approved to be used in youngsters as younger as 12 in Europe, the US and Canada.
The corporate mentioned it has chosen a dose of 10 micrograms in youngsters between 5 and 11 years of age and three micrograms for infants in age-group of six months to 5 years -old.
Inoculating youngsters and younger folks is taken into account a crucial step towards reaching “herd immunity” and taming the COVID-19 pandemic.
View hyperlink »